COPD Therapeutics Market
A Detailed Analysis of COPD Therapeutics Market by COPD Therapeutics Drug Class, Bronchodilators, Steroids, Phosphodiesterase-4 inhibitors, Theophylline, Antibiotics, COPD Therapeutics Delivery Systems, Oral, Inhalation
How Combination Therapy is Impacting the COPD Therapeutics Market Outlook- Explore Opportunities with FMI
COPD Therapeutics Market Outlook (2023 to 2033)
The global COPD therapeutics market garnered a market value of US$ 12,144.1 million in 2023 and is expected to accumulate a market value of US$ 20,035.5 million by 2033, registering a CAGR of 5.1% over the forecast period.
The growth of the COPD therapeutics market can be attributed to an increase in smoking and genetic disorders. The market for COPD therapeutics registered a CAGR of 4.8% during the historical period.
| Report Attribute | Details |
|---|---|
|
Estimated Base Year Value (2022) |
US$ 11,668.2 million |
|
Expected Market Value (2023) |
US$ 12,144.1 million |
|
Anticipated Forecast Value (2033) |
US$ 20,035.5 million |
|
Projected Growth Rate (2023 to 2033) |
5.1% CAGR |
Surgery is recommended in case of the extreme severity of COPD, including lung volume reduction surgery, lung transplant, and bullectomy, and the adoption of COPD therapeutics rises as COPD is one of the leading causes of death worldwide.
Triple therapy, LABA-ICS, LAMA-ICS, and other combination medications are examples of combination therapy. As using a bronchodilator and a corticosteroid separately is less effective, combination therapy is becoming more popular, positively impacting the market outlook.
Combination therapy is superior to monotherapy for treating the signs and symptoms of chronic obstructive pulmonary disease and enhancing the quality of life. Moreover, the COPD therapeutics market growth is anticipated to rise as a result of a rise in the number of patients who are successfully treated with combination therapy but did not improve after receiving bronchodilators or corticosteroids.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Which Are Some Prominent Drivers of the COPD Therapeutics Market?
Lifestyle change is responsible for increasing the habits like smoking and increase in the number of genetic disorders, which in turn are responsible for raising the number of COPD patients and expanding the COPD therapeutics market size.
Other factors that can boost the revenue from the COPD therapeutics market are rising healthcare expenditures, leading to the adoption of COPD treatments in emerging economies. The demand for COPD therapeutics can also be owed to an increase in the level of awareness which has also led to the early diagnosis of COPD so that people can go for the treatment of the disease.
Additionally, it is projected that new product launches and advances in the global market for Chronic Obstructive Pulmonary therapeutics in respiratory illness therapy will aid in the industry's expansion. Betterment of the healthcare infrastructure in the Asia Pacific and the Middle East, and Africa is also responsible for the revenue growth of the COPD therapeutics market during the forecast period.
What Are the Challenges Faced by the COPD Therapeutics Market?
Factors that can limit the growth of the therapeutic enzymes over the forecast period include the fact that not all patients suffering from COPD are aware of the fact that they are suffering from the disease and therefore do not go for the treatment of the disease.
Also, sometimes people get to know about their disease when only medication and therapies, and surgery can’t cure the disease becomes mandatory. This factor can also lead to sluggish growth in the revenue from the COPD therapeutics market.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
How Is the Prevalence of COPD Escalating Demand for COPD Therapeutics in North America?
| Region | Market Share % (2022) |
|---|---|
|
North America |
36.2% |
According to National Heart, Lung, and Blood Institute, more than 15 million people are affected by COPD. This has increased the dependency on COPD therapeutics to access early treatment for the same. In addition, the strong presence of key players in the region is accelerating the growth of the COPD therapeutics market.
Moreover, developing health infrastructure is fuelling the growth of the COPD therapeutics market. Thus, due to the aforementioned reasons, North America is expected to possess more than 36.2% market share for COPD therapeutics in 2023.
How are Government Initiatives Augmenting Demand for COPD Therapeutics in Europe?
| Region | Market Share % (2022) |
|---|---|
|
Europe |
29.8% |
According to Asthma Lung UK+, more than 1.3 million people suffer from COPD. This has led the country's government to design initiatives to create awareness regarding COPD. In addition, the increasing geriatric population in the country is contributing to the growth of the COPD market.
Furthermore, the growing inclination towards early treatment positively influences the market's growth. Thus, due to the reasons mentioned above, Europe is expected to hold a more than 29.8% COPD therapeutics market share in 2023.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
What Are A Few Key Start-Ups in The COPD Therapeutics Market?
Key start-up players in the COPD therapeutics market are Omnispirant, Atriva Therapeutics, Altavant Sciences, Exvastat, and ReAlta Life Sciences.
- ReAlta Life Sciences, a key start-up in the COPD therapeutics market develops engineered peptides to harness the power of the immune system. In addition, the drug also works for COVID-19 patients.
- Spirosure, a US-based start-up, raised US$ 32 million in funding, aimed at making the lives of people with respiratory disorders like COPD, asthma, cystic fibrosis, and pulmonary hypertension better by developing breath-based diagnostic and monitoring tools.
How Strong Is the Competition in The COPD Therapeutics Market?
The COPD market is consolidated, with only a few significant firms present, and the primary strategies used by the top companies are product portfolio expansion and mergers and acquisitions.
One of the major recent developments in the COPD therapeutics market is when AstraZeneca’s Bevespi Aerospherehas received approval in China as a maintenance treatment to relieve symptoms in patients suffering from COPD.
Key players
- Pfizer Inc.
- Adamis Laboratories Inc.
- GlaxoSmithKline plc.
- AstraZeneca
- Merk & Co.
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries
Report Scope
| Report Attribute | Details |
|---|---|
|
Market Value in 2023 |
US$ 12,144.1 million |
|
Market Value in 2033 |
US$ 20,035.5 million |
|
Growth Rate |
CAGR of 5.1% from 2023 to 2033 |
|
Base Year for Estimation |
2022 |
|
Historical Data |
2018 to 2022 |
|
Forecast Period |
2023 to 2033 |
|
Quantitative Units |
Revenue in US$ million and CAGR from 2023 to 2033 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the COPD Therapeutics Industry Survey
By Component:
- COPD Therapeutics Drug Class
- Bronchodilators
- Steroids
- Phosphodiesterase-4 inhibitors
- Theophylline
- Antibiotics
- COPD Therapeutics Delivery Systems
- Oral
- Inhalation
By End User:
- Hospitals
- Private Clinics
- Outpatient Departments
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Frequently Asked Questions
What is the market value in 2023?
The market in 2023 is valued at US$ 12,144.1 million.
How was the market’s historical performance?
The market rose at a 4.8% CAGR from 2018 to 2022.
What is the likely CAGR until 2033?
The market will register a 5.1% CAGR until 2033.
What will be the market value in 2033?
By 2033, the market will reach US$ 20,035.5 million.
What was Europe’s market share in 2022?
Europe’s market share in 2022 was 29.8%.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Component 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2023 to 2033 5.3.1. Drug Class 5.3.2. Bronchodilators 5.3.3. Steroids 5.3.4. Phosphodiesterase-4 inhibitors 5.3.5. Theophylline 5.3.6. Antibiotics 5.3.7. Delivery Systems 5.3.8. Oral 5.3.9. Inhalation 5.4. Y-o-Y Growth Trend Analysis By Component, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Component, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Private Clinics 6.3.3. Outpatient Departments 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Component 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Component 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Component 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Component 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Component 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Component 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Component 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Component 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Component 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Component 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Component 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Component 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Component 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Component 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Component 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Component 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Component 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Component 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Component 15.5.2.2. By End User 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Component 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Component 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Component 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Component 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Component 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Component 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Component 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Component 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Component 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Component 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Component 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Component 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Component 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Component 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Component 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Component 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Component 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Component 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Component 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Pfizer Inc. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Adamis Laboratories Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. GlaxoSmithKline plc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. AstraZeneca Plc 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Merk & Co. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Novartis AG 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Mylan N.V. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Teva Pharmaceutical Industries 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Abbott Laboratories 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Almirall 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Astellas Pharma 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Boehringer Ingelheim Pharmaceuticals, Inc. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. Orion Corporation 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. Sunovion Pharmaceuticals, Inc. 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 8: Latin America Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 11: Western Europe Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Eastern Europe Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 20: East Asia Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Component, 2018 to 2033 Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Component, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 7: Global Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 8: Global Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 9: Global Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 10: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 13: Global Market Attractiveness by Component, 2023 to 2033 Figure 14: Global Market Attractiveness by End User, 2023 to 2033 Figure 15: Global Market Attractiveness by Region, 2023 to 2033 Figure 16: North America Market Value (US$ Million) by Component, 2023 to 2033 Figure 17: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 22: North America Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 23: North America Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 24: North America Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 28: North America Market Attractiveness by Component, 2023 to 2033 Figure 29: North America Market Attractiveness by End User, 2023 to 2033 Figure 30: North America Market Attractiveness by Country, 2023 to 2033 Figure 31: Latin America Market Value (US$ Million) by Component, 2023 to 2033 Figure 32: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 37: Latin America Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 43: Latin America Market Attractiveness by Component, 2023 to 2033 Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 46: Western Europe Market Value (US$ Million) by Component, 2023 to 2033 Figure 47: Western Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 52: Western Europe Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 58: Western Europe Market Attractiveness by Component, 2023 to 2033 Figure 59: Western Europe Market Attractiveness by End User, 2023 to 2033 Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 61: Eastern Europe Market Value (US$ Million) by Component, 2023 to 2033 Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 73: Eastern Europe Market Attractiveness by Component, 2023 to 2033 Figure 74: Eastern Europe Market Attractiveness by End User, 2023 to 2033 Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 76: South Asia and Pacific Market Value (US$ Million) by Component, 2023 to 2033 Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 88: South Asia and Pacific Market Attractiveness by Component, 2023 to 2033 Figure 89: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033 Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 91: East Asia Market Value (US$ Million) by Component, 2023 to 2033 Figure 92: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 97: East Asia Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 98: East Asia Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 103: East Asia Market Attractiveness by Component, 2023 to 2033 Figure 104: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 106: Middle East and Africa Market Value (US$ Million) by Component, 2023 to 2033 Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033 Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Component, 2018 to 2033 Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Component, 2023 to 2033 Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033 Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 118: Middle East and Africa Market Attractiveness by Component, 2023 to 2033 Figure 119: Middle East and Africa Market Attractiveness by End User, 2023 to 2033 Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
